What Causes Autoimmune Hepatitis
Autoimmune hepatitis results from a complex interplay between genetic susceptibility (particularly specific HLA alleles and immune-regulatory genes) and environmental triggers that together break immune tolerance, leading to autoreactive T-cell and B-cell mediated destruction of hepatocytes. 1
Genetic Predisposition
The genetic foundation of AIH is well-established and varies by disease subtype and ethnicity:
Type 1 AIH (associated with antinuclear and anti-smooth muscle antibodies):
- In European populations: HLA-DRB103:01 and DRB104:01 alleles
- Different HLA associations exist in South American and East Asian populations 1
Type 2 AIH (associated with liver-kidney microsomal antibody):
- HLA-DRB103, DRB107, and DQB1*02:01 alleles 1
Key immune-regulatory genes identified through genome-wide association studies:
- CTLA4 (at 2q33.3): encodes a T-cell receptor involved in costimulatory pathways 1
- SYNPR (at 3p14.2) 1
- AIRE gene: mutations cause autoimmune polyendocrinopathy with autoimmune-like hepatitis; this gene encodes a transcription factor essential for immune tolerance 1
These genetic factors provide susceptibility but do not guarantee disease development—additional environmental triggers are required 2.
Environmental Triggers
Environmental factors likely generate self-antigens through xenobiotic modification of host proteins or molecular mimicry when genetic risk factors are present 1:
Identified risk factors include:
- Urinary tract infections
- Oral contraceptives
- Current smoking
- Vaccinations (varicella, rubella, pertussis, pneumococcus) 1
Protective factors include:
- History of mumps or rheumatic fever
- Pregnancies
- Hormone replacement therapy 1
Other potential triggers described in the literature:
- Altered gut microbiome composition 3, 2
- Certain medications and herbal agents (may trigger classical AIH or induce liver disease with autoimmune features) 2
- Vitamin D deficiency 2
- Alcohol 2
Environmental factors may predispose to AIH through epigenetic changes 1.
Immunopathogenic Mechanism
Once triggered, AIH is characterized by a specific immune cascade:
Initial injury is driven by:
- Innate immune response orchestrated by type II natural killer cells 1, 3
- This recruits adaptive immune cells to sites of lobular and interface hepatitis 1
Sustained autoimmune attack involves:
- CD4+ T helper cells (predominantly Th1 and Th17 subsets) with inflammatory phenotype and marked TNF production—these are the primary drivers of hepatocyte injury 1, 3
- Autoreactive CD4+ T cells have a B-helper phenotype, explaining both elevated immunoglobulins and the efficacy of anti-B-cell therapies 3
- B cells and plasma cells producing autoantibodies and secreting IgG 1
- Dendritic cells presenting antigens and interacting with T cells 1
Failed immune regulation:
- Thymic-derived regulatory T cells (Tregs) normally prevent AIH by controlling tissue-damaging effector T cells 1
- In AIH, there are numerical and functional defects in Tregs, allowing autoimmune liver injury to persist 2, 4
Clinical Caveat
Important ethnic and demographic variations exist: Sub-Saharan African, Indian, and Brazilian patients present younger with more severe disease compared to Western populations 5. Black patients in the US face greater risk of hospitalization and death compared to white counterparts 5. These disparities underscore that while the fundamental genetic-environmental interaction drives AIH pathogenesis, disease expression and severity are modified by additional population-specific factors.
The absence of a single pathognomonic cause means diagnosis requires integration of clinical, biochemical, serological, and histological features rather than identification of one specific etiologic agent 6.